Tiffany Shih provides economic support in commercial litigation and regulatory investigations, with a focus on antitrust and competition matters in the life sciences and healthcare industries.
Selected industry experience
- Healthcare, life sciences, and media
Academic research and publications
- “Short-term Costs of Preeclampsia to the United States Health Care System,” with W. Stevens, D. Incerti, T. Ton, H. Lee, D. Peneva, G. Macones, B. Sibai, and A. Jena, American Journal of Obstetrics and Gynecology 3, 2017.
- “Product Safety Spillovers and Market Viability for Biologic Drugs,” with J. Romley, International Journal of Health Economics and Management 17: 2, 2017.
- “Incremental Net Monetary Benefit of Ocrelizumab Relative to Subcutaneous Interferon b-1a,” with M. Frasco, D. Incerti, O. Diaz Espinosa, D. Vania, and N. Thomas, Journal of Medical Economics 20: 10, 2017.
- “Reconsidering the Economic Value of Multiple Sclerosis Therapies,” with C. Wakeford, D. Meletiche, J. Sussell, A. Chung, Y. Liu, J. Shim, and D. Lakdawalla, American Journal of Managed Care 22: 11, 2016.
- “The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health,” with D. Peneva, X. Xu, A. Sutton, E. Triche, R. Ehrenkranz, M. Paidas, and W. Stevens, American Journal of Perinatology 33: 4, 2016.
- “Agricultural Innovation,” with B. Wright, in Accelerating Energy Innovation: Insights from Multiple Sectors, R.M. Henderson, and R.G. Newell, eds. (NBER, 2009).
Previous experience
- Precision Health Economics, Los Angeles, CA
- University of California, Los Angeles, CA
- Fuqua School of Business, Duke University, Durham, NC
|
